Locally advanced breast cancers: the EUSOMA experience
Peter A. van Dam(University of Antwerp), Serena Scomersi(Scuola Internazionale Superiore di Studi Avanzati), A. Baldissera(Laboratoire National de Référence), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Jakob de Vries(Tilburg University), Luca Despini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Elisabetta Benozzi(Centro di Riferimento Oncologico), Kwok‐Leung Cheung(University of Nottingham), Carla Cedolini(Ospedale Santa Maria della Misericordia di Udine), A. Prové(GZA Ziekenhuizen Campus Sint-Augustinus), Antonio Ponti(Piedmont Reference Center for Epidemiology and Cancer Prevention), Daniele Generali(University of Trieste), Jenny Heiman(Sahlgrenska University Hospital), Matteo Ghilli, Francesco Sardanelli(IRCCS Policlinico San Donato), Simona Grossi(Agenzia Sanitaria Regionale Abruzzo), Ruth Helfgott, Isabel T. Rubio(Clinica Universidad de Navarra), Alessandra Huscher(Fondazione Poliambulanza Istituto Ospedaliero), Maria João Cardoso(Champalimaud Foundation), Pedro Gouveia(Champalimaud Foundation), Alessandra Gennari(Ente Ospedaliero Ospedali Galliera), Giovanna Romanucci, Fabio Corsi(Istituti Clinici Scientifici Maugeri), Boudewijn Dullens(AZ Klina), Barbara Bussels(Cambridge Collaborative (United States)), Martine Berlière(Cliniques Universitaires Saint-Luc), Giuseppe Melucci(Ospedale Cervesi di Cattolica), Cynthia Aristei(University of Perugia), José Luís Fougo(Hospital de São João), Evelyn Despierre(KU Leuven), Francesco Caruso(University of Catania), Donatella Santini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Gianluca Fogazzi(University of Brescia), Lucio Fortunato(Azienda Ospedaliera San Giovanni Addolorata), S. Marquette(Jessa Hospital), Antonio Esgueva(Universitat Autònoma de Barcelona), Monika Elisabeth Edith Lüthy(Ospedale di Bolzano), Lorenza Marotti, Federico Piacentini(Azienda Unita' Sanitaria Locale Di Modena), Lorenzo Rossi(Ente Ospedaliero Cantonale), Catarina Rodrigues dos Santos(University of Lisbon), Julie Verhaegen(Antwerp University Hospital), Karol Rogowski(Medical University of Białystok), Mariano Tomatis(Piedmont Reference Center for Epidemiology and Cancer Prevention), Henk Loobuyck(AZ Sint-Lucas), Giuseppe Curigliano(European Institute of Oncology), Caldana(University of Verona), Chiara Annunziata Pasqualina Anghelone(University Hospital Foundation)
Cited by 1
Related Papers
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k